Abina et al., 2015 - Google Patents
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndromeAbina et al., 2015
View PDF- Document ID
- 1864950827643930011
- Author
- Abina S
- Gaspar H
- Blondeau J
- Caccavelli L
- Charrier S
- Buckland K
- Picard C
- Six E
- Himoudi N
- Gilmour K
- McNicol A
- Hara H
- Xu-Bayford J
- Rivat C
- Touzot F
- Mavilio F
- Lim A
- Treluyer J
- Héritier S
- Lefrère F
- Magalon J
- Pengue-Koyi I
- Honnet G
- Blanche S
- Sherman E
- Male F
- Berry C
- Malani N
- Bushman F
- Fischer A
- Thrasher A
- Galy A
- Cavazzana M
- Publication year
- Publication venue
- Jama
External Links
Snippet
Importance Wiskott-Aldrich syndrome is a rare primary immunodeficiency associated with severe microthrombocytopenia. Partially HLA antigen–matched allogeneic hematopoietic stem cell (HSC) transplantation is often curative but is associated with significant …
- 102000001392 Wiskott-Aldrich Syndrome Protein 0 title abstract description 111
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abina et al. | Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome | |
| Mishra et al. | TGF-β and Eomes control the homeostasis of CD8+ regulatory T cells | |
| Routes et al. | Statewide newborn screening for severe T-cell lymphopenia | |
| Grunebaum et al. | Bone marrow transplantation for severe combined immune deficiency | |
| Samimi et al. | Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression | |
| Cao et al. | Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-γ, and GM-CSF and diminished IL-10 production | |
| Orange | Human natural killer cell deficiencies | |
| Arnone et al. | Acute myeloid leukemia stem cells: the challenges of phenotypic heterogeneity | |
| Ruck et al. | Alemtuzumab in multiple sclerosis: mechanism of action and beyond | |
| Schirmer et al. | Enriched CD161high CCR6+ γδ T cells in the cerebrospinal fluid of patients with multiple sclerosis | |
| Howson et al. | MR1-restricted mucosal-associated invariant T cells and their activation during infectious diseases | |
| Gaspar et al. | Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector | |
| Randall et al. | DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice | |
| Meyer-Bahlburg et al. | Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation | |
| Zhang et al. | Hereditary and acquired hemophagocytic lymphohistiocytosis | |
| Zühlke et al. | CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease | |
| Gilli et al. | Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis | |
| Levine et al. | Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity | |
| Baekkevold et al. | A role for CCR4 in development of mature circulating cutaneous T helper memory cell populations | |
| Zuo et al. | Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease | |
| Akbayram et al. | The clinical outcome of 260 pediatric ITP patients in one center | |
| Mancini et al. | X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis | |
| Cull et al. | Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS | |
| Zhang et al. | Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis | |
| Fang et al. | The cell-surface 5′-nucleotidase CD73 defines a functional T memory cell subset that declines with age |